Amphastar Pharmaceuticals Surges 11% on Strong Q3 Results

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded11 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2198245

Show notes

Amphastar Pharmaceuticals shares surged by nearly eleven percent following their impressive third-quarter financial results, which beat analyst predictions. The company reported strong revenue and earnings, driven by robust sales of Baqsimi and Primatene Mist. Despite a slight lowering of their price target, analyst firm Needham maintained a Buy rating. This significant jump, however, still leaves the company down nearly twenty-eight percent since the start of the year.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.